Multiple Weekly Dalbavancin Dosing for the Treatment of Native Vertebral Osteomyelitis Caused by Methicillin-Resistant Staphylococcus Aureus: A Case Report
- 9 December 2017
- journal article
- case report
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 18, 1315-1319
Abstract
BACKGROUND:Native vertebral osteomyelitis (NVO) is a common form of hematogenous osteomyelitis, with Staphylococcus aureus (S. aureus) being the most commonly isolated organism. Dalbavancin is approved by the US Food and Drug Administration (FDA) for...Keywords
This publication has 17 references indexed in Scilit:
- 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in AdultsaClinical Infectious Diseases, 2015
- Vertebral OsteomyelitisNew England Journal of Medicine, 2010
- Pyogenic Vertebral Osteomyelitis: A Systematic Review of Clinical CharacteristicsSeminars in Arthritis and Rheumatism, 2009
- Distribution of Radioactivity in Bone and Related Structures following Administration of [ 14 C]Dalbavancin to New Zealand White RabbitsAntimicrobial Agents and Chemotherapy, 2007
- Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002–2003Epidemiology and Infection, 2007
- MR Imaging Findings in Spinal Infections: Rules or Myths?Radiology, 2003
- Vertebral Osteomyelitis: Long‐Term Outcome for 253 Patients from 7 Cleveland‐Area HospitalsClinical Infectious Diseases, 2002
- Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980–1990Journal of Infection, 1997
- MR imaging of vertebral osteomyelitis revisited.American Journal of Roentgenology, 1996
- Pyogenic Vertebral Osteomyelitis: Analysis of 20 Cases and ReviewClinical Infectious Diseases, 1995